Inhibitor of cardiac tachyarrhythmias

Details Inhibitor of cardiac tachyarrhythmias Inhibitor of cardiac tachyarrhythmias

2008-03-25

2008-03-25

Tsang, Cecilia J. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

10927616

ABSTRACT:
Methods of preventing sustained monomorphic ventricular tachycardia following myocardial ischemia, decreasing infarct size and/or decreasing the incidence and/or maximum intrinsic rate of very rapid ventricular triplets following myocardial ischemia is disclosed. The methods involve administering an effective amount of a composition that inhibits substantial loss of beta-adrenergic receptor kinase (β-ARK) activity and/or β-ARK expression.

REFERENCES:
patent: 6015557 (2000-01-01), Tobinick
patent: 6096711 (2000-08-01), Sherman et al.
patent: 6177077 (2001-01-01), Tobinick
patent: 6271199 (2001-08-01), Brand et al.
patent: 6379666 (2002-04-01), Tobinick
patent: 6419934 (2002-07-01), Tobinick
patent: 6423321 (2002-07-01), Tobinick
patent: 6428787 (2002-08-01), Tobinick
patent: 6531128 (2003-03-01), Wax et al.
patent: 6537549 (2003-03-01), Tobinick
patent: 6548527 (2003-04-01), Rahman et al.
Jaber M et al “Essential Role of Beta-Adrenergic Receptor Kinase I in Cardiac Development and Function”, Nov. 1, 1996, Proc. Natl. Acad. Sci. vol. 93, pp. 12974-12979.
Brendel J et al “Blockers of the Kv1.5 Channel For The Treatment of Atrial Arrhythmias”, Nov. 2002, Expert Opin. Ther. Patents vol. 12. pp. 1589-1598.
Cross et al., “Overexpression of the cardiac beta2-adrenergic receptor and expression of a beta-adrenergic receptor kinase (BARK1) inhibitor both increase myocardial contractility but have differential effects on suspectibility to ischemic injury”. Circulation Research, 85:1077-1085 (1999), especially abstract and especially pp. 1079 and 1081.
Ungerer, M. et al., Activation of B-Adrenergic Receptor Kinase During Myocardial Ischemia. Circulation Research 79:455-460 (1996), see entire document.
White et al., “Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction”. Proc. Natl. Acad. Sci. USA 97:5428-5433 (2000), especially p. 5429, Figure 1.

Affiliated with

Also associated with

Rating

Inhibitor of cardiac tachyarrhythmias does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitor of cardiac tachyarrhythmias, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitor of cardiac tachyarrhythmias will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3946629